SCHEMBL8340963

SCHEMBL8340963

CN[C@H](Cc1c[nH]c2ccccc12)c1nc(-c2ccccc2)c[nH]1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR84 Q9NQS5 5/20 0.48
HTR2A P28223 3/20 0.46
HTR1A P08908 2/20 0.46
ADRB1 P08588 1/20 0.46
ADRA2A P08913 1/20 0.46
SLC6A2 P23975 1/20 0.46
HTR1D P28221 1/20 0.46
HTR1B P28222 1/20 0.46
HTR2C P28335 1/20 0.46
HTR1E P28566 1/20 0.46
SLC6A4 P31645 1/20 0.46
HTR7 P34969 1/20 0.46
HTR2B P41595 1/20 0.46
HTR6 P50406 1/20 0.46
SLC6A3 Q01959 1/20 0.46
SSTR1 P30872 1/20 0.46
SSTR3 P32745 2/20 0.46
MAPT P10636 2/20 0.45
KDM4E B2RXH2 2/20 0.45
APAF1 O14727 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20976919 0.89 SSTR1 (0.49) GPR84HTR2AHTR1AADRB1ADRA2A
SCHEMBL22680197 0.88 HTR2A (0.47) GPR84HTR2AHTR1AADRB1ADRA2A
SCHEMBL21263604 0.88 HTR2A (0.45) GPR84HTR2AHTR1AADRB1ADRA2A
SCHEMBL12582465 0.87 SSTR3 (0.50) GPR84HTR2AHTR1AADRB1ADRA2A
SCHEMBL13579138 0.86 SSTR3 (0.49) SSTR1SSTR3MAPTKDM4EAPAF1
SCHEMBL14341130 0.85 SSTR3 (0.48) SSTR1SSTR3MAPTKDM4EAPAF1
SCHEMBL2342532 0.85 SSTR3 (0.52) SSTR1SSTR3MAPTKDM4EAPAF1
SCHEMBL1929182 0.85 SSTR1 (0.46) GPR84HTR2AHTR1AADRB1ADRA2A
SCHEMBL1928410 0.85 KCNT1 (0.48) GPR84SSTR1SSTR3MEN1KMT2A
SCHEMBL1927672 0.85 KCNT1 (0.48) GPR84SSTR1SSTR3MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200347110-A1 Composition and Methods for Stimulating Gastrointestinal Motility IPSEN PHARMA S.A.S. (FR) 2020-11-05 US disclosed
EP-1937262-B1 COMPOSITION FOR USE IN TREATING GASTROINTESTINAL DYSMOTILITY IPSEN PHARMA (FR) 2019-05-08 EP disclosed
US-20170037104-A1 Composition and Methods for Stimulating Gastrointestinal Motility IPSEN PHARMA S.A.S. (FR) 2017-02-09 US disclosed
US-9499599-B2 Composition and methods for stimulating gastrointestinal motility IPSEN PHARMA S.A.S. (FR) 2016-11-22 US disclosed
US-8981054-B2 Compositions and methods for stimulating gastrointestinal motility IPSEN PHARMA S.A.S. (FR) 2015-03-17 US disclosed
US-20110166069-A1 COMPOSITIONS AND METHODS FOR STIMULATING GASTROINTESTINAL MOTILITY BIOMEASURE, INCORPORATED 2011-07-07 US disclosed
EP-1542716-B1 GROWTH HORMONE RELEASING PEPTIDES IPSEN PHARMA (FR) 2009-11-04 EP disclosed
WO-2004014415-A1 GROWTH HORMONE RELEASING PEPTIDES SOCIETE DE CONSEIL DE RECHERCHES ET D'APPLICATIONS SCIENTIFIQUES, S.A.S. (FR) 2004-02-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170037104-A1 Composition and Methods for Stimulating Gastrointestinal Motility GIPR, VIP, GRPR GPR84 209/4885HTR2A 690/4885HTR1A 423/4885
US-20110166069-A1 COMPOSITIONS AND METHODS FOR STIMULATING GASTROINTESTINAL MOTILITY GIPR, VIP, GRPR GPR84 251/4885HTR2A 850/4885HTR1A 508/4885
US-20200347110-A1 Composition and Methods for Stimulating Gastrointestinal Motility GIPR, VIP, GRPR GPR84 209/4885HTR2A 690/4885HTR1A 423/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.